- Citations, last 5 years
- 407
- Works, last 5 years
- 24
- h-index
- 62
- Scientists listed
- 1
- Grants since 2016
- 8
Grants received
2021–2025 · contract · N44
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
Mel Ruzicka · Intralytix (United States) · funded by National Institutes of Health
2021–2022 · contract · N43
A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications
Mel Ruzicka · Intralytix (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Bacteriophage-based approach for managing Shigella infections
Wilbur H. Chen · Intralytix (United States) · funded by National Institutes of Health
2020–2026 · cooperative agreement · U01
Bacteriophage-based approach for managing Shigella infections
Wilbur H. Chen · Intralytix (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Bacteriophage-based approach for managing Shigella infections
Wilbur H. Chen · Intralytix (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Bacteriophage-based approach for managing Shigella infections
Wilbur H. Chen · Intralytix (United States) · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Bacteriophage-based approach for managing Shigella infections
Wilbur H. Chen · Intralytix (United States) · funded by National Institutes of Health
2016–2018 · grant · Standard Grant
SBIR Phase I: Mobile Platform for Student Goal-Setting & Engagement
Lori Silverman · Intralytix (United States) · funded by National Science Foundation